Literature DB >> 7840218

Leukotoxin, 9,10-epoxy-12-octadecenoate causes pulmonary vasodilation in rats.

T Ishizaki1, H Takahashi, T Ozawa, S W Chang, N F Voelkel.   

Abstract

Leukotoxin (Lx), a cytochrome P-450-dependent metabolite of linoleate synthesized by neutrophils or synthesized by OH- and linoleate in neutrophil cell membranes, has been recovered in lung lavages of patients with the adult respiratory distress syndrome. We studied the direct vasoactive effects of Lx and linoleate, its parent compound, in the rat pulmonary circulation. In isolated rat lungs perfused at constant flow with a physiological salt solution, Lx (but not linoleate) caused a biphasic response, an initial transient vasoconstriction followed by a more prolonged vasodilation. The latter response was only evident when the pulmonary vascular tone was increased with either alveolar hypoxia (0% O2) or KCl (20 mM). The pressor response to angiotensin II was also attenuated in the presence of Lx. The vasodilatory response in perfused lungs was attenuated by methylene blue (2 x 10(-5) M), a putative inhibitor of the soluble guanylate cyclase but not by pretreatment with meclofenamate (10(-5) M), a cyclooxygenase inhibitor. In isolated pulmonary arterial (PA) rings preconstricted either with phenylephrine (5 x 10(-9) M), endothelin-1 (10(-8) M), or KCl (30 mM), Lx (but not linoleate) caused dose-dependent relaxation. The relaxing effect of Lx on endothelium-intact rings was attenuated by NG-monomethyl-L-arginine or methylene blue. The magnitude of the hypoxic contraction of PA rings was attenuated in the presence of Lx. Whereas the mechanism of Lx-induced vasoconstriction is not clear, we conclude that Lx causes vasodilation in rat lungs and that the vasodilatory component is to a large degree endothelium-derived relaxing factor-dependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840218     DOI: 10.1152/ajplung.1995.268.1.L123

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

Review 1.  Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies.

Authors:  Kelsey Hildreth; Sean D Kodani; Bruce D Hammock; Ling Zhao
Journal:  J Nutr Biochem       Date:  2020-08-20       Impact factor: 6.048

2.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

Authors:  C Morisseau; M H Goodrow; D Dowdy; J Zheng; J F Greene; J R Sanborn; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model.

Authors:  Arzu Ulu; Benjamin B Davis; Hsing-Ju Tsai; In-Hae Kim; Christophe Morisseau; Bora Inceoglu; Oliver Fiehn; Bruce D Hammock; Robert H Weiss
Journal:  J Cardiovasc Pharmacol       Date:  2008-10       Impact factor: 3.105

4.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase.

Authors:  M F Moghaddam; D F Grant; J M Cheek; J F Greene; K C Williamson; B D Hammock
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.